Somatostatin Receptor Imaging in NPC, EBV Related Cancers

Somatostatin Receptor Imaging in Nasopharyngeal Cancer, Epstein-Barr Virus (EBV) Related Cancers and Other Rare Tumors

The study aims to describe the avidity of somatostatin receptors in locally advanced, metastatic and locally recurrent nasopharyngeal cancer (NPC) and to determine the proportion of NPC patients with high somatostatin receptor density that may benefit from future somatostatin targeted therapeutic trial plans. The investigators also aim to determine the presence of somatostatin receptors in other EBV related cancers.

Inclusion Criteria:

• Locally advanced, metastatic or locally recurrent NPC that are going for FDG PET as part of their investigations
• Patients that have gone for Ga-68 DOTATATE imaging before are eligible for repeat imaging
• Histologically confirmed NPC
• Above 21 years of age

Exclusion Criteria:

• Patients below 21 years of age
• Pregnant and breast feeding ladies